Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
Box 208028
New Haven, CT 06510Phone+1 203-785-5756Fax+1 203-200-6950
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
CT State Medical License 2010 - 2025
NY State Medical License 2007 - 2010- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
- Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
- Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.Rabea Sobirey, Nickolai Matuschewski, Moritz Gross, MingDe Lin, Tabea Kao
European Radiology. 2025-01-01 - Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms.Johannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein
Scientific Reports. 2024-12-17 - 1 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01
Lectures
- Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer pat...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
Dr. Stacey Stein and Dr. Neal Fischbach Appointed as Assistant Medical Directors at Yale Cancer Center Clinical Trials OfficeOctober 15th, 2021
New Investigation into PD-1 Blockade for Hepatocellular CarcinomaJanuary 10th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
